NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAMS E-009-2005-0-PCT-02 Development Of A Model Human Immunoinflammatory Disease PCT PCT PCT/EP05/004740 Abandoned
NIDDK E-352-2003-0-PCT-02 Expression Of Structural Proteins Of West Nile Virus In Insect Cells PCT PCT PCT/US2005/015319 Expired
NCI E-248-2002-0-US-04 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF NEUROENDOCRINE LUNG CANCER US National Stage 10/533,459 Abandoned
NIDDK E-352-2003-0-EP-04 Expression Of Structural Proteins Of West Nile Virus In Insect Cells EP National Stage 05746277.2 Abandoned
NCI E-073-2007-0-DE-01 Cellular Assay method for identifying PKCthetha inhibitors DE ORD 102005020754.5 Abandoned
E-269-2006-1-US-01 Opioid Receptors Ligands And Methods For Their Preparation US 60/667,238 Abandoned
NIAID E-285-2002-0-US-03 Lutzomyia Longipalpis Polypeptides and Methods of Use US National Stage 10/533,811 7485306 Expired PDF
NCI E-138-2005-0-US-01 Infectious Particle Composition and Methods of Use Thereof US 60/676,023 Abandoned
NIDCR E-179-2005-0-US-01 Isolation, Cloning, and Characterization of New Adeno-Associated Virus Serotypes US 60/676,604 Abandoned
NCI E-025-2003-1-US-02 Method for Prophylaxis and Treatment of Her-2/neu Tumors US ORD 11/119,332 Abandoned
NCI E-278-2003-0-PCT-02 Use Of Interferon-alpha Hybrids And Mutants Against The Corona Virus (SARS) PCT PCT PCT/US2005/014800 Expired
CC E-008-2003-0-US-03 Scavenger Receptor B1 Targeting For The Treatment Of Infection, Sepsis And Inflammation US National Stage 10/533,103 Abandoned
NCI E-244-2004-0-PCT-02 The Ube2G2 Binding Domain in The Ubiquitin Ligase Gp78 and Methods of Use Thereof PCT PCT PCT/US2005/14635 Abandoned
NCI E-076-2004-0-PCT-02 Epitope-E-enhanced of a Human CD4 HIV Epitope PCT PCT PCT/US2005/014569 Expired
NCI E-167-2007-0-NZ-10 Antigenic Peptides NZ National Stage 539606 Abandoned
NCI E-062-1996-0-US-04 PROSTATE SPECIFIC ANTIGEN OLIGO-EPITOPE PEPTIDE US CON 11/114,069 Abandoned
NCI E-289-2002-0-JP-06 Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta JP National Stage 2004-547201 Abandoned
NHLBI E-014-2004-0-PCT-02 Monoclonal Antibody MP804 And Its Detection Of Primitive Stem Cells In Adult Skeletal Muscle That Mature In Vitro Into Neuronal Cells PCT PCT PCT/US2005/14176 Expired
NHLBI E-014-2004-0-JP-06 USE OF A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS STEM CELLS JP National Stage 2007-509728 Abandoned
NHLBI E-014-2004-0-EP-05 USE OF MONOCLONAL ANTIBODY THAT SPECIALLY BINDS STEM CELLS EP National Stage 05779962.9 Abandoned
NCI E-142-2005-0-US-01 A Single Ribozyme To Catalyze Both Trimming And Trans-Acting Catalysis275 US 60/675,076 Abandoned
NHLBI E-073-2005-0-US-01 Adiabatic T2 Preparation Sequence for Magnetic Resonance Imaging with Reduced B1 Sensitivity US 60/679,949 Abandoned
NHLBI E-014-2004-0-AU-03 Use Of A Monoclonal Antibody That Specifically Binds Stem Cells. AU National Stage 2005246216 Abandoned
NHLBI E-014-2004-0-CA-04 USE OF A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS STEM CELLS CA National Stage 2563677 Abandoned
NCI E-066-1998-0-US-10 Anthrax Lethal Factor is A Mapk Kinase Protease US DIV 11/112,137 7056693 Abandoned PDF
NIDDK E-165-2005-0-US-01 Automated Non-Invasive Real-Time ARF Detection System And Method Using Modified Raman Technology US 60/564,744 Abandoned
NCI E-045-2004-2-PCT-01 Methods and Compositions for Diagnosing AIDS and other Diseases and Conditions Involving Immune System Activattion PCT PCT COMB PCT/US2005/13554 Abandoned
NCI E-289-2002-0-US-03 Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta US National Stage 10/532,374 Abandoned
NCI E-103-2004-1-PCT-01 Development Of Novel Protein "Expression Tags" For High Yield And Soluble Proteins PCT PCT COMB PCT/US05/013553 Abandoned
NINDS E-181-2002-0-HK-08 Methods and Devices for Intramuscular Stimulation of Upper Airway and Swallowing Muscle Groups HK National Stage 06100229.7 Abandoned
NIAMS E-011-2005-0-NZ-09 Cross-linked Polymer Matrices, And Methods Of Making And Using Same NZ National Stage 539520 Abandoned
NHGRI E-020-2003-1-DE-08 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS DE EP 03809146.8 Abandoned
NHGRI E-020-2003-1-FR-09 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS FR EP 03809146.8 Abandoned
NCI E-035-2002-0-US-03 Backbone Substituted Bifunctional DOTA Ligands, Complexes, and Compositions Thereof, and Methods of Using Same US National Stage 10/525,673 7368100 Abandoned PDF
NCI E-191-2002-0-US-03 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF US National Stage 10/521,930 7205334 Expired PDF
NCI E-105-2004-2-PCT-01 Germline Sequence Variants of Humanized Antibodies and Methods of Making and Using Them PCT PCT COMB PCT/US2005/012662 Abandoned
NIAID E-003-2005-0-US-01 Treatment and prevention of IBD using Mutant and Chimeric Il-13 Molecules US 60/671,624 Abandoned
NCI E-155-2005-0-US-01 T Cell-Binding Epitopes From The Human Papillomavirus Type 16 E2 Region That Induce Significant CD8+ T Cell Reponse And CTL Lysis Activity Both Bound To HLA.A2 And And When Pulsed As Peptide US 60/671,463 Abandoned
NCI E-158-2005-0-US-01 Identification Of H2-Db And HLA A2 Specific CD8 Epitopes From VEGFR2/KDR That Inhibit Angiogenesis By Vaccination US 60/671,867 Abandoned
NCI E-348-2004-0-US-01 North-2'-Dexoxy-Methanocarbathymidine as Antiviral Agent for Treatment of Kaposi's Sarcoma-Associated Perpes Virus US 60/671,691 Abandoned
NIAID E-250-2005-0-US-01 Methods and Compositions for treating and preventing fibrosis (Wyeth Ref.: AM101991L1) US 60/671,374 Abandoned
NICHD E-038-2005-0-US-01 Ultrahigh-Resolution Fiber-optic Confocal Microscopy Beyond The Diffraction Limit N The Nonometric Scale US 60/671,104 Abandoned
NICHD E-309-2000-0-US-04 Probe Using Diffuse-Reflectance Spectroscopy US CON 11/105,180 6990369 Abandoned PDF
NIDCD E-099-2005-0-US-01 Human Sweet And Umami Taste Receptor Variants US 60/671,173 Abandoned
NIAID E-173-2004-1-AU-02 Methods of Using Adenoviral Vector to Induced an Immune Response AU National Stage 2005243730 Abandoned
NCI E-093-1996-3-US-16 O2-Glycosylated Diazeniumdiolates As Nitric Oxide (NO)-Releasing Prodrugs US DIV 11/104,232 7081524 Expired PDF
NIAID E-173-2004-1-PCT-01 Methods of Using Adenoviral Vector to Induced an Immune Response PCT PCT COMB PCT/US2005/12291 Expired
NIAID E-173-2004-1-EP-12 Methods of Using Adenoviral Vector to Induced an Immune Response EP DIV 12180322.5 Abandoned
NIAID E-173-2004-1-EP-05 Methods of Using Adenoviral Vector to Induced an Immune Response EP National Stage 05778761.6 Abandoned
NIAID E-173-2004-1-CA-03 Methods of Using Adenoviral Vector to Induced an Immune Response CA National Stage 2563396 Abandoned